One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved ...

The trial is part of a larger trend towards targeted chemotherapies, Santin says, many of which may come onto the market in the next few decades.

Cosm Medical Corp., a medical technology company specializing in personalized gynecological devices, today announced that it has entered into a licensing and collaboration agreement with Duke Health ...

The Mount Sinai Health System is opening the Carolyn Rowan Center for Women’s Health and Wellness, a transformative new model for women’s health that brings together multidisciplinary clinical ...

The Mount Sinai Health System is opening the Carolyn Rowan Center for Women's Health and Wellness, a transformative new model for women's health that brings together multidisciplinary clinical ...

AI chatbots answered health questions with 76% accuracy, raising concerns about the reliability of AI medical advice and ...

Chlamydia screening increased with a medical assistant directed EMR alert. Read more on the clinical findings.

Immunotherapies such as so-called checkpoint inhibitors activate the body's own immune system to fight cancer cells and have revolutionized the treatment of many types of tumor. In breast cancer, ...

One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer ...

A largely overlooked space between cells in women's brains may hold the key to understanding memory loss tied to estrogen ...

News and commentary from the psychiatry world ...